CRISPR-Assisted DNA Detection: A Novel dCas9-Based DNA Detection Technique.

Area of Science:

• Molecular Biology
• Biotechnology
• Diagnostic Assays

Background:

• Nucleic acid detection is crucial for diagnostics, particularly during pandemics like COVID-19.
• Existing methods face limitations in speed, sensitivity, and specificity due to traditional amplification and hybridization.
• There is an urgent need for simple, rapid, and highly accurate nucleic acid detection techniques.

Purpose of the Study:

• To develop a novel CRISPR-Cas9-assisted DNA detection (CADD) method.
• To overcome the limitations of conventional nucleic acid detection techniques.
• To provide a rapid, sensitive, and specific diagnostic tool.

Main Methods:

• Developed CRISPR-Cas9-assisted DNA detection (CADD) using dCas9 and single guide RNAs (sgRNAs).
• Incubated DNA samples with sgRNAs, dCas9, and probes on solid supports at room temperature.
• Utilized fluorescent or colorimetric signal readout for detection.

Main Results:

• Successfully detected bacterial, cancer cell, and viral DNA using CADD.
• Demonstrated high-risk human papillomavirus (HPV) detection in 64 clinical samples.
• Achieved complete detection within 30 minutes at room temperature.

Conclusions:

• CADD is a versatile and efficient method for nucleic acid detection.
• The technique shows significant promise for rapid on-the-spot diagnostics and point-of-care testing.
• CADD offers a valuable alternative to traditional nucleic acid detection methods.